Coronavirus
Most Popular
More news about the pandemic
Markets The Market Thinks the Fed Is Wrong. Why That’s Dangerous.
Cava stock doubles in debut amid signs of IPO thaw, Adobe’s AI future, and other news to start your day.
FDA advisers endorse updating COVID vaccines to target latest omicron strain
The COVID-19 vaccines are on track for a big recipe change this fall.
Biotech and Pharma The FDA Is Prepping for Fall Covid Boosters. The Next Step Is Today.
The agency's vaccines advisors are meeting to settle on a design for this year’s updated Covid-19 vaccine.
As COVID public health emergency ends, ‘whack-a-mole’ virus won’t be easy to track
The U.S. COVID-19 public health emergency comes to an end on Thursday, but the fight against COVID goes on.
U.S. to lift most federal COVID-19 vaccine mandates next week
Vaccine requirements for federal workers and federal contractors, as well as foreign air travelers to the U.S., will end May 11.
Coronavirus What WHO’s New Covid-19 Vaccine Guidance Means for Pfizer and Moderna Stock
The two companies have said they expect roughly 100 million Covid-19 vaccines doses to be administered in the U.S. this year.
Biotech and Pharma BioNTech Stock Is Falling. Blame the Covid Vaccine Outlook.
The German biotech that partnered with Pfizer to develop a Covid-19 vaccine expects fewer vaccinations and lowered levels of boosting this year.
The stock market hit a pandemic bottom 3 years ago. Here’s how it has performed since then.
It has been three years since the U.S. stock market hit its COVID-19 bottom as the global economy suddenly shut down at the onset of the pandemic in early 2020.
Markets The Bank Turmoil Isn’t Over. What It Means for the Fed Looking Forward.
Moderna’s CEO is faces a Senate grilling over $130 Covid-19 shot, Google expands public access to its ‘Bard’ chatbot, and other news to start your day.
Health experts call on officials to counter anti-vaccine activism: ‘This is a matter of life and death.’
Researchers write in The Lancet of the dangers of anti-vaccine activism, which exploded during the coronavirus pandemic and continues to spread.
WHO panel is reviewing whether COVID vaccines need updating, as agency monitors 7 omicron subvariants
Most of the week's COVID news is focused on vaccines, including the big slide in Moderna's revenue caused by falling demand.
